$417 GLP1 – 2 Month Paid in Full

GLP1 has shown promise as a treatment for obesity. In clinical trials, GLP1 has been found to lead to significant weight loss compared to placebo, as well as improve several metabolic markers such as blood pressure, lipid levels, and insulin resistance. Additionally, GLP1 has been associated with a reduction in the risk of cardiovascular events in people with obesity, suggesting potential benefits beyond weight loss alone. This medication offers a new option for individuals struggling with obesity, particularly those who have not had success with lifestyle modifications alone.

*Purchasing the program does not qualify a patient for treatment. An appointment with the provider will be scheduled for you promptly after purchase. NOT AVAILABLE to AR, CA, MI, KS, AL, ID, NC​.